Cartesian Therapeutics | Competitive Intelligence Profile
Cartesian Therapeutics is a clinical-stage biotechnology company focused on pioneering mRNA cell therapies for the treatment of autoimmune...
Cartesian Therapeutics is a clinical-stage biotechnology company focused on pioneering mRNA cell therapies for the treatment of autoimmune diseases. The company is developing innovative therapies, including its lead asset Descartes-08, which is in Phase 2b clinical development for generalized myasthenia gravis and Phase 2 for systemic lupus erythematosus. Cartesian's mission is to extend the potential of cell therapy to patients with autoimmune conditions.
Website
Headquarters
Frederick, Maryland
Size
51-200 employees
Industry
Biotechnology Research
Specialities
Immunotherapy, Oncology, Molecular Biology, Immunology, Myasthenia Gravis, ARDS, Cell Therapy, NETs, Gene Therapy, Cancer Research, multiple myeloma, SLE, mRNA, CAR-T, Systemic lupus erythematosus, Autoimmunity, Autoimmune Disease, Lupus
🛍️ Cartesian Therapeutics Product and Pricing News →
👔 Cartesian Therapeutics CEO, Management and Leadership Team →
⚔️ Cartesian Therapeutics Alternatives and Competitors →
💼 Cartesian Therapeutics Hiring and Layoffs →
🤖 Cartesian Therapeutics Developer, Integration and Automation News →
📈 Cartesian Therapeutics Financials, Fundraising and Valuation News →
🛍️ Cartesian Therapeutics Product and Pricing News
👔 Cartesian Therapeutics CEO, Management and Leadership Team
-
Director
[email protected] -
President and CEO[email protected]
-
Chief Technology Officer
-
Chief Financial Officer[email protected]
⚔️ Cartesian Therapeutics Alternatives and Competitors
- Minerva Biotechnologies |
- Asc Therapeutics |
- ImStem Biotechnology |
- Miltenyi Biomedicine |
- Amgen |
- Bristol Myers Squibb |
- Chugai Pharma USA, Inc. |
- Werewolf Therapeutics |
- Vor Biopharma |
- Tmunity Therapeutics |
- IM Therapeutics |
- Intensity Therapeutics |
- Vitruvian Biomedical |
- Collaborative Medicinal Development |
- AnTolRx |
- Novartis |
- Gilead Sciences |
- Regeneron |
- Zymeworks Inc. |
- Sangamo Therapeutics, Inc. |
- bluebird bio |
- Immunocore |
- Travere Therapeutics |
- Indivior |
- Edgewise Therapeutics |
- Ocular
💼 Cartesian Therapeutics Hiring and Layoffs
- On April 29, 2025, Cartesian Therapeutics announced that their Chief Technology Officer, Dr. Metin Kurtoglu, will transition to a consultant role from May 1, 2025, to April 30, 2026.
- Cartesian Therapeutics is currently seeking a Head of Clinical Safety and Development in the United States.
🤖 Cartesian Therapeutics Developer, Integration and Automation News
📈 Cartesian Therapeutics Financials, Fundraising and Valuation News
People also viewed
- Atara Biotherapeutics |
- Tune Therapeutics |
- Kapadi |
- 2seventy bio |
- Ridecell |
- MOQO |
- Joyride |
- Urban Sharing
